Investigation of Multisequence Magnetic Resonance Imaging for Detection of Recurrent Tumor after Transurethral Resection for Bladder Cancer

Journal of Computer Assisted Tomography

Volumn 40, Issue 2, 2016, Pages 201-205

  Rosenkrantz, Andrew B ^a   Ego Osuala, Islamiat O ^a   Khalef, Victoria ^a   Deng, Fang Ming ^b   Taneja, Samir S ^a   Huang, William C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

bladder cancer; contrast enhanced imaging; cystoscopy; diffusion weighted imaging; MRI

Indexed keywords

BACTERIOLOGY; DISEASES; PATHOLOGY; PATIENT TREATMENT; TUMORS;

BLADDER CANCERS; CONTRAST-ENHANCED IMAGING; CYSTOSCOPY; DIFFUSION WEIGHTED IMAGING; FALSE POSITIVE; LOW GRADE; MULTI-SEQUENCES; RECURRENT TUMORS; TRANSURETHRAL RESECTIONS; TUMOR RECURRENCES;

MAGNETIC RESONANCE IMAGING;

BCG VACCINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

AGED; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CYSTOSCOPY; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRANSURETHRAL RESECTION; UROGRAPHY; BLADDER; IMAGE ENHANCEMENT; OBSERVER VARIATION; PATHOLOGY; PROCEDURES; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS;

AGED; CONTRAST MEDIA; CYSTOSCOPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84954348746     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0000000000000363     Document Type: Article

References (20)

1. American Cancer Society. Cancer Facts and Figures 2014. Atlanta, GA: American Cancer Society; 2014.
2. Vikram R, Sandler CM, Ng CS,. Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. AJR Am J Roentgenol. 2009; 192: 1481-1487.
3. Rouprêt M, Babjuk M, Comperat E, European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol. 2013; 63: 1059-1071.
4. Saad A, Hanbury DC, McNicholas TA, A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int. 2002; 89: 369-373.
5. Grossman HB, Stenzl A, Fradet Y, Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J Urol. 2012; 188: 58-62.
6. Gakis G, Kruck S, Stenzl A,. Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers? Curr Opin Urol. 2010; 20: 388-392.
7. Vikram R, Sandler CM, Ng CS,. Imaging and staging of transitional cell carcinoma: part 2, upper urinary tract. AJR Am J Roentgenol. 2009; 192: 1488-1493.
8. Wang HJ, Pui MH, Guo Y, Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. Abdom Imaging. 2014; 39: 135-141.
9. El-Assmy A, Abou-El-Ghar ME, Refaie HF, Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. BJU International. 2012; 110 (pt B): E622-E627.
10. Sadow CA, Silverman SG, O'Leary MP, Bladder cancer detection with CT urography in an Academic Medical Center. Radiology. 2008; 249: 195-202.
11. Rosenkrantz AB, Mussi TC, Melamed J, Bladder cancer: utility of MRI in detection of occult muscle-invasive disease. Acta Radiol. 2012; 53: 695-699.
12. Rosenkrantz AB, Obele C, Rusinek H, Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness. Abdom Imaging. 2015; 40: 327-332.
13. Rosenkrantz AB, Haghighi M, Horn J, Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results. AJR Am J Roentgenol. 2013; 201: 1254-1259.
14. Lopez-Beltran A, Montironi R,. Non-invasive urothelial neoplasms: according to the most recent WHO classification. Eur Urol. 2004; 46: 170-176.
15. Jones TD, Cheng L,. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. J Urol. 2006; 175: 1995-2003.
16. Babjuk M, Burger M, Zigeuner R, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013; 64: 639-653.
17. Dobson MJ, Carrington BM, Collins CD, The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol. 2001; 56: 94-98.
18. Ma W, Kang SK, Hricak H, Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma. AJR Am J Roentgenol. 2009; 192: 1494-1500.
19. Kim JK, Park SY, Ahn HJ, Bladder cancer: analysis of multi-detector row helical CT enhancement pattern and accuracy in tumor detection and perivesical staging. Radiology. 2004; 231: 725-731.
20. Raman SP, Fishman EK,. Bladder malignancies on CT: the underrated role of CT in diagnosis. AJR Am J Roentgenol. 2014; 203: 347-354.